phenoxybenzamine has been researched along with Diseases, Metabolic in 3 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lambotte, L | 1 |
| Rocmans, P | 1 |
| Ettinger, PO | 1 |
| Oldewurtel, HA | 1 |
| Dzindzio, B | 1 |
| Sethi, V | 1 |
| Regan, TJ | 1 |
| Savoie, LL | 1 |
3 other studies available for phenoxybenzamine and Diseases, Metabolic
| Article | Year |
|---|---|
[Toxi-infectious shock].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Chlorpromazine; Digitalis G | 1973 |
Glucose intolerance in nonischemic cardiac disease. Role of cardiac output and adrenergic function.
Topics: Adolescent; Adult; Aged; Cardiac Output; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Female; Glu | 1971 |
[Role of antikaliuretics and catecholamines in the prevention of cardiac necroses of metabolic origin].
Topics: Adrenal Cortex Hormones; Amiloride; Animals; Catecholamines; Digitoxin; Diuretics; Epinephrine; Hear | 1971 |